JS']JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

被引:491
作者
Kudo, Masatoshi [1 ]
Matsui, Osamu [2 ]
Izumi, Namiki [3 ]
Iijima, Hiroko [4 ]
Kadoya, Masumi [5 ]
Imai, Yasuharu [6 ]
Okusaka, Takuji [7 ]
Miyayama, Shiro [8 ]
Tsuchiya, Kaoru [3 ]
Ueshima, Kazuomi [1 ]
Hiraoka, Atsushi [9 ]
Ikeda, Masafumi [10 ]
Ogasawara, Sadahisa [11 ]
Yamashita, Tatsuya [12 ]
Minami, Tetsuya [13 ]
Yamakado, Koichiro [14 ]
机构
[1] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 5898511, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa, Japan
[3] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[4] Hyogo Coll Med, Dept Internal Med, Div Hepatobiliary & Pancreat Dis, Nishinomiya, Hyogo, Japan
[5] Shinshu Univ, Sch Med, Dept Radiol, Nagano, Japan
[6] Ikeda Municipal Hosp, Dept Gastroenterol, Osaka, Japan
[7] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[8] Fukuiken Saiseikai Hosp, Dept Diagnost Radiol, Fukui, Japan
[9] Ehime Prefectural Cent Hosp, Dept Gastroenterol, Matsuyama, Ehime, Japan
[10] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Chiba, Japan
[11] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan
[12] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan
[13] Kanazawa Univ Hosp, Dept Radiol, Kanazawa, Ishikawa, Japan
[14] Mie Univ, Sch Med, Dept Intervent Radiol, Tsu, Mie, Japan
关键词
Clinical practice guidelines; Definition of transarterial chemoembolization failure; Hepatocellular carcinoma; Japan Society of Hepatology; Liver Cancer Study Group of Japan; ACID-ENHANCED MRI; DIETHYLENETRIAMINE PENTAACETIC ACID; DIFFUSION-WEIGHTED MRI; HYPOVASCULAR HYPOINTENSE NODULES; ARTERIAL-DOMINANT PHASE; GADOXETIC ACID; HEPATOBILIARY-PHASE; MAGNETIC-RESONANCE; HEPATIC NODULES; SIGNAL INTENSITY;
D O I
10.1159/000343875
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma proposed by the Japan Society of Hepatology was updated in June 2014 at a consensus meeting of the Liver Cancer Study Group of Japan. Three important items have been updated: the surveillance and diagnostic algorithm, the treatment algorithm, and the definition of transarterial chemoembolization (TACE) failure/refractoriness. The most important update to the diagnostic algorithm is the inclusion of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a first line surveillance/diagnostic tool. Another significant update concerns removal of the term "lipiodol" from the definition of TACE failure/refractoriness. Copyright (C) 2014 S. Karger AG, Basel
引用
收藏
页码:458 / 468
页数:11
相关论文
共 111 条
  • [1] Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging
    Akai, Hiroyuki
    Matsuda, Izuru
    Kiryu, Shigeru
    Tajima, Taku
    Takao, Hidemasa
    Watanabe, Yasushi
    Imamura, Hiroshi
    Kokudo, Norihiro
    Akahane, Masaaki
    Ohtomo, Kuni
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (11) : 2973 - 2977
  • [2] Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: Comparison with triple phase 64 detector row helical CT
    Akai, Hiroyuki
    Kiryu, Shigeru
    Matsuda, Izuru
    Satou, Jirou
    Takao, Hidemasa
    Tajima, Taku
    Watanabe, Yasushi
    Imamura, Hiroshi
    Kokudo, Norihiro
    Akahane, Masaaki
    Ohtomo, Kuni
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2011, 80 (02) : 310 - 315
  • [3] Usefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tomography
    Alaboudy, Alshimaa
    Inoue, Tatsuo
    Hatanaka, Kinuyo
    Chung, Hobyung
    Hyodo, Tomoko
    Kumano, Seishi
    Murakami, Takamichi
    Moustafa, Ehab Fawzy Abdou
    Kudo, Masatoshi
    [J]. ONCOLOGY, 2011, 81 : 66 - 72
  • [4] Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma
    An, Chansik
    Park, Mi-Suk
    Kim, Dowhan
    Kim, Yeo-Eun
    Chung, Woo-Suk
    Rhee, Hyungjin
    Kim, Myeong-Jin
    Kim, Ki Whang
    [J]. EUROPEAN RADIOLOGY, 2013, 23 (04) : 924 - 930
  • [5] Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI
    An, Chansik
    Park, Mi-Suk
    Jeon, Hyae-Min
    Kim, Yeo-Eun
    Chung, Woo-Suk
    Chung, Yong Eun
    Kim, Myeong-Jin
    Kim, Ki Whang
    [J]. EUROPEAN RADIOLOGY, 2012, 22 (08) : 1701 - 1708
  • [6] [Anonymous], 2014, HPB SURG
  • [7] [Anonymous], HEPATOLOGY
  • [8] Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
    Arii, Shigeki
    Sata, Michio
    Sakamoto, Michiie
    Shimada, Mitsuo
    Kumada, Takashi
    Shiina, Shuichiro
    Yamashita, Tatsuya
    Kokudo, Norihiro
    Tanaka, Masatoshi
    Takayama, Tadatoshi
    Kudo, Masatoshi
    [J]. HEPATOLOGY RESEARCH, 2010, 40 (07) : 667 - 685
  • [9] A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma
    Ariizumi, Shun-ichi
    Kitagawa, Koichi
    Kotera, Yoshihito
    Takahashi, Yutaka
    Katagiri, Satoshi
    Kuwatsuru, Ryohei
    Yamamoto, Masakazu
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (04) : 575 - 585
  • [10] Hepatocellular carcinoma in patients with chronic liver disease: A comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT
    Baek, C. -K.
    Choi, J. -Y.
    Kim, K. -A.
    Park, M. -S.
    Lim, J. S.
    Chung, Y. E.
    Kim, M. -J.
    Kim, K. -W.
    [J]. CLINICAL RADIOLOGY, 2012, 67 (02) : 148 - 156